N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy

International Journal of Cardiology

Volumn 143, Issue 3, 2010, Pages 349-352

  Garcia, Santiago ^a   Akbar, Muhammad S ^a   Ali, Syed S ^a   Kamdar, Forum ^a   Tsai, Michael Y ^a   Duprez, Daniel A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Hypertension; Left ventricular hypertrophy; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; ELECTRONIC MEDICAL RECORD; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

AGED; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 77956612518     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.070     Document Type: Article

References (21)

1. J.M. Sullivan, R. Van der Zwaag, F. El-Zeky, K.B. Ramaanathan, and D.M. Mirvis LV hypertrophy: effect on survival J Am Coll Cardiol 22 1993 508 513
2. D. Levy, R.J. Garrison, D.D. Savage, W.B. Kannel, and W.P. Castelli Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study N Engl J Med 322 1990 1561 1566
3. O. Nakagawa, Y. Ogawa, and H. Itoh Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload J Clin Invest 96 1995 1280 1287
4. J.L. Januzzi Jr., C.A. Camargo, and S. Anwaruddin The N-terminal pro-BNP investigation of dyspnea in the emergency department (PRIDE) study Am J Cardiol 95 2005 948 954
5. A.S. Maisel, P. Krishnaswamy, and R.M. Nowak Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
6. J.A. de Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med. 345 2001 1014 1021
7. C. Kragelund, B. Grønning, and L. Køber B-Type natriuretic peptide and mortality in stable coronary disease N Engl J Med 352 2005 666 675
8. S.K. James, J. Lindback, J. Tilly, and A. Siegbahn Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes; a GUSTO-IV sub study J Am Coll Cardiol 48 2006 1146 1154
9. G.C. Fonarow, W.F. Peacock, C.O. Phillips, M.M. Givertz, and M. Lopatin Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure J Am Coll Cardiol 49 2007 1943 1950
10. J.L. Januzzi, R. van Kimmenade, and J. Lainchbury NT-pro BNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
11. F. Hartmann, M. Packer, and A.J. Coats Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a sub-study of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial Circulation 110 2004 1780 1786
12. L.B. Daniels, and A.S. Maisel Natriuretic peptides J Am Coll Cardiol 50 2007 2357 2368
13. N. Kucher, G. Printzen, and S.Z. Goldhaber Prognostic role of brain natriuretic peptide in acute pulmonary embolism Circulation 107 2003 2545 2547
14. S. Talwar, A. Siebenhofer, B. Williams, and L. Ng Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N Terminal proBNP Heart 83 2000 278 282
15. R. Lang, M. Bierig, and R. Devereux Recommendation for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European Society of cardiology J Am Soc Echocardiogr 18 2005 1440 1463
16. B.C. Astor, S. Yi, and L. Hiremath N-Terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease. The African American study of kidney disease and hypertension Circulation 117 2008 1685 1692
17. G. Aurigemena Diastolic heart failure-a common and lethal condition by any name N Engl J Med 355 2006 308 310
18. T.E. Owan, D.O. Hodge, R.M. Herges, S.J. Jacobsen, V.L. Roger, and M.M. Redfield Trends in prevalence and outcome of heart failure with preserved ejection fraction N Engl J Med 355 2006 251 259
19. J.N. Cohn, D.A. Duprez, and G.A. Grandits Arterial elasticity as part of a comprehensive assessment of cardiovascular risk and drug treatment Hypertension 46 2005 217 220
20. J.N. Cohn, L. Hoke, and W. Whitwam Screening for early detection of cardiovascular disease in asymptomatic individuals Am Heart J 146 2003 679 685
21. AJ Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150